Animal Health: Trade between Switzerland and the European Union and placing on the market
* Unless indicated otherwise, any reference to an act shall mean that act as amended before 31 December 2025.
European Union | Switzerland
Regulation (EU) 2016/429 of the European Parliament and of the Council of 9 March 2016 on transmissible animal diseases and amending and repealing certain acts in the area of animal health (‘Animal Health Law’) (OJ L 84, 31.3.2016, p. 1) and the delegated and implementing acts based on this Regulation adopted by 31 December 2025;
For provisions on official controls performed by the competent authorities to verify compliance with the rules on the agri-food chain concerning trade in terrestrial animals between Switzerland and the European Union:
Regulation (EU) 2017/625 of the European Parliament and of the Council of 15 March 2017 on official controls and other official activities performed to ensure the application of food and feed law, rules on animal health and welfare, plant health and plant protection products, amending Regulations (EC) No 999/2001, (EC) No 396/2005, (EC) No 1069/2009, (EC) No 1107/2009, (EU) No 1151/2012, (EU) No 652/2014, (EU) 2016/429 and (EU) 2016/2031 of the European Parliament and of the Council, Council Regulations (EC) No 1/2005 and (EC) No 1099/2009 and Council Directives 98/58/EC, 1999/74/EC, 2007/43/EC, 2008/119/EC and 2008/120/EC, and repealing Regulations (EC) No 854/2004 and (EC) No 882/2004 of the European Parliament and of the Council, Council Directives 89/608/EEC, 89/662/EEC, 90/425/EEC, 91/496/EEC, 96/23/EC, 96/93/EC and 97/78/EC and Council Decision 92/438/EEC (Official Controls Regulation) (Official Controls Regulation) (OJ L 95, 7.4.2017, p. 1);
Commission Implementing Regulation (EU) 2021/403 of 18 March 2021 laying down rules for the application of Regulations (EU) 2016/429 and (EU) 2017/625 of the European Parliament and of the Council as regards model animal health certificates and model animal health/official certificates, for the entry into the Union and movements between Member States of consignments of certain categories of terrestrial animals and germinal products thereof, official certification regarding such certificates and repealing Decision 2010/470/EU (OJ L 113, 31.3.2021, p. 1);
Article 107 (with the exception of paragraph 6) of Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary products and repealing Directive 2001/82/EC (OJ L 4 of 7.1.2019, p. 43), in conjunction with Article 37(5) thereof.
Ordinance of 27 June 1995 on epizootic diseases (OFE; RS 916.401);
Ordinance of 18 November 2015 governing trade involving the importation, transit and exportation of animals and animal products with the Member States of the EU, Iceland, Norway and Northern Ireland (OITE-UE; RS 916.443.11);
DFI Ordinance of 18 November 2015 governing trade involving the importation, transit and exportation of animals and animal products with the Member States of the EU, Iceland, Norway and Northern Ireland (OITE-EU-DFI; RS 916.443.111);
Federal Law of 29 April 1998 on agriculture (LAgr; RS 910.1), and in particular Article 160 (Mandatory accreditation);
Federal Act of 15 December 2000 on medicinal products and medical devices (LPTh; RS 812.21);
Ordinance of 18 August 2004 on veterinary medicinal products (OMédV; RS 812.212.27);
Technical guidelines on the prophylactic and metaphylactic use of medicinal products containing antimicrobial agents in productive animals, as published on 31 May 2026.
Inspections shall be carried out under the responsibility of the Joint Veterinary Committee in accordance in particular with Article 116 of Regulation (EU) 2017/625 and Article 57 of the Law on epizootic diseases.
Animals traded between the Member States of the European Union and Switzerland shall move under the same conditions as animals traded between the Member States of the European Union. Where necessary, these products are accompanied by the health certificates required for trade between the Member States of the European Union or defined in this Annex and available in the TRACES system.
For the purposes of this Annex, Switzerland is recognised as fulfilling the conditions provided for in Chapter 4 of Part II of Regulation (EU) 2016/429, Commission Delegated Regulation (EU) 2020/689 [Commission Delegated Regulation (EU) 2020/689 of 17 December 2019 supplementing Regulation (EU) 2016/429 of the European Parliament and of the Council as regards rules for surveillance, eradication programmes, and disease-free status for certain listed and emerging diseases (OJ L 174, 3.6.2020, p. 211, ELI: http://data.europa.eu/eli/reg_del/2020/689/oj).] and Commission Implementing Regulation (EU) 2021/620 [Commission Implementing Regulation (EU) 2021/620 of 15 April 2021 laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council as regards the approval of the disease-free and non-vaccination status of certain Member States or zones or compartments thereof as regards certain listed diseases and the approval of eradication programmes for those listed diseases (OJ L 131, 16.4.2021, p. 78, ELI: http://data.europa.eu/eli/reg_impl/2021/620/oj).] as regards the diseases listed in the sites of the Commission ‘Surveillance, eradication programmes and disease-free status – Food Safety’ and of the Federal Food Safety and Veterinary Office ‘National Surveillance Programme’.
For diseases for which Switzerland does not yet have approval of disease-free status, Switzerland shall present to the Joint Veterinary Committee the information required to obtain that status pursuant to Regulation (EU) 2016/429. On the basis of this information, the Joint Veterinary Committee agrees to update the information available on the websites mentioned above.
The Federal Food Safety and Veterinary Office shall immediately notify the Commission of any change in the conditions on which recognition of that status is based for one of the diseases listed in this paragraph. The situation shall be examined within the Joint Veterinary Committee.
For the purposes of this Annex, Switzerland is recognised as fulfilling the conditions laid down in point 1, Section 2, Chapter 3, Part I of Annex IV to Implementing Regulation (EU) 2020/689 as regards bovine tuberculosis. In order to maintain its status as having an officially brucellosis-free bovine herd, Switzerland undertakes to meet the following conditions:
any animal of the bovine species suspected of being infected with brucellosis shall be reported to the competent authorities and the animal concerned shall undergo the official tests for brucellosis, comprising at least two serological tests with complement fixation and a microbiological examination of suitable samples taken in cases of abortion;
until such time as suspicion of the disease is lifted, i.e. when the tests provided for in point (a) have produced negative results, the officially brucellosis-free status of the herd to which the animal (or animals) of the bovine species suspected of infection belongs shall be suspended.
Switzerland shall apply the same provisions as those of Article 107 (with the exception of paragraph 6) of Regulation (EU) 2019/6, in conjunction with Article 37(5) thereof on the use of antimicrobial medicinal products in animals intended for production, in accordance with its legislation listed in Section A above.
Switzerland does not authorise either the placing on the market of medicinal products intended for production animals containing one of the antimicrobials or groups of antimicrobials listed in point (2) or (3) of the Annex to Commission Implementing Regulation (EU) 2022/1255 [Commission Implementing Regulation (EU) 2022/1255 of 19 July 2022 designating antimicrobials or groups of antimicrobials reserved for the treatment of certain infections in humans, in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council (OJ L 191, 20.7.2022, p. 58, ELI: http://data.europa.eu/eli/reg_impl/2022/1255/oj).] or the use in production animals of medicinal products for human use containing these antimicrobials or groups of antimicrobials.
Discussions will take place in the Joint Veterinary Committee on amendments to the above-mentioned European Union legislation requiring adaptation of the Swiss provisions.
Therefore, Switzerland shall not be considered as a third country for the purposes of Article 118 of Regulation (EU) 2019/6 until 1 July 2028.
It shall immediately inform the Joint Veterinary Committee of any further changes to its legislation on antimicrobial medicinal products intended for production animals.
This paragraph shall be reviewed by the Joint Veterinary Committee before 1 July 2028.
For consignments of hatching eggs to the European Union, the Swiss authorities undertake to comply with the rules on marking laid down in Commission Regulation (EC) No 617/2008 [Commission Regulation (EC) No 617/2008 of 27 June 2008 laying down detailed rules for implementing Council Regulation (EC) No 1234/2007 as regards marketing standards for eggs for hatching and farmyard poultry chicks (OJ L 168, 28.6.2008, p. 5, ELI: http://data.europa.eu/eli/reg/2008/617/oj).].
In the case of consignments from Switzerland to Finland, Sweden or Denmark, the Swiss authorities undertake to supply the guarantees concerning salmonella required under EU legislation.
* Unless indicated otherwise, any reference to an act shall mean that act as amended before 31 December 2025.
European Union | Switzerland
Regulation (EU) 2016/429 of the European Parliament and of the Council of 9 March 2016 on transmissible animal diseases and amending and repealing certain acts in the area of animal health (‘Animal Health Law’) (OJ L 84, 31.3.2016, p. 1) and the delegated and implementing acts based on this Regulation adopted by 31 December 2025;
For provisions on official controls performed by the competent authorities to verify compliance with agri-food chain rules concerning trade in aquaculture animals and products between Switzerland and the European Union:
Regulation (EU) 2017/625 of the European Parliament and of the Council of 15 March 2017 on official controls and other official activities performed to ensure the application of food and feed law, rules on animal health and welfare, plant health and plant protection products, amending Regulations (EC) No 999/2001, (EC) No 396/2005, (EC) No 1069/2009, (EC) No 1107/2009, (EU) No 1151/2012, (EU) No 652/2014, (EU) 2016/429 and (EU) 2016/2031 of the European Parliament and of the Council, Council Regulations (EC) No 1/2005 and (EC) No 1099/2009 and Council Directives 98/58/EC, 1999/74/EC, 2007/43/EC, 2008/119/EC and 2008/120/EC, and repealing Regulations (EC) No 854/2004 and (EC) No 882/2004 of the European Parliament and of the Council, Council Directives 89/608/EEC, 89/662/EEC, 90/425/EEC, 91/496/EEC, 96/23/EC, 96/93/EC and 97/78/EC and Council Decision 92/438/EEC (Official Controls Regulation) (Official Controls Regulation) (OJ L 95, 7.4.2017, p. 1);
Commission Implementing Regulation (EU) 2020/2236 of 16 December 2020 laying down rules for the application of Regulations (EU) 2016/429 and (EU) 2017/625 of the European Parliament and of the Council as regards model animal health certificates for the entry into the Union and the movements within the Union of consignments of aquatic animals and of certain products of animal origin from aquatic animals, official certification regarding such certificates and repealing Regulation (EC) No 1251/2008 (OJ L 442, 30.12.2020, p. 410);
Article 107 (with the exception of paragraph 6) of Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary products and repealing Directive 2001/82/EC (OJ L 4 of 7.1.2019, p. 43), in conjunction with Article 37(5) thereof.
Ordinance of 27 June 1995 on epizootic diseases (OFE; RS 916.401);
Ordinance of 18 November 2015 governing trade involving the importation, transit and exportation of animals and animal products with the Member States of the EU, Iceland, Norway and Northern Ireland (OITE-EU; RS 916.443.11);
DFI Ordinance of 18 November 2015 governing trade involving the importation, transit and exportation of animals and animal products with the Member States of the EU, Iceland, Norway and Northern Ireland (OITE-EU-DFI; RS 916.443.111);
Federal Law of 29 April 1998 on agriculture (LAgr; RS 910.1), and in particular Article 160 (Mandatory accreditation);
Federal Act of 15 December 2000 on medicinal products and medical devices (LPTh; RS 812.21);
Ordinance of 18 August 2004 on veterinary medicinal products (OMédV; RS 812.212.27);
Technical guidelines on the prophylactic and metaphylactic use of medicinal products containing antimicrobial agents in productive animals, as published on 31 May 2026.
Inspections shall be carried out under the responsibility of the Joint Veterinary Committee in accordance in particular with Article 116 of Regulation (EU) 2017/625 and Article 57 of the Law on epizootic diseases.
Animals traded between the Member States of the European Union and Switzerland shall move under the same conditions as animals traded between the Member States of the European Union. Where necessary, these products shall be accompanied by the health certificates required for trade between the Member States of the European Union and available in the TRACES system.
For the purposes of this Annex, Switzerland is recognised as fulfilling the conditions provided for in Chapter 4 of Part II of Regulation (EU) 2016/429, Commission Delegated Regulation (EU) 2020/689 [Commission Delegated Regulation (EU) 2020/689 of 17 December 2019 supplementing Regulation (EU) 2016/429 of the European Parliament and of the Council as regards rules for surveillance, eradication programmes, and disease-free status for certain listed and emerging diseases (OJ L 174, 3.6.2020, p. 211, ELI: http://data.europa.eu/eli/reg_del/2020/689/oj).] and Commission Implementing Regulation (EU) 2021/620 [Commission Implementing Regulation (EU) 2021/620 of 15 April 2021 laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council as regards the approval of the disease-free and non-vaccination status of certain Member States or zones or compartments thereof as regards certain listed diseases and the approval of eradication programmes for those listed diseases (OJ L 131, 16.4.2021, p. 78, ELI: http://data.europa.eu/eli/reg_impl/2021/620/oj).] as regards the diseases listed in the sites of the Commission ‘Surveillance, eradication programmes and disease-free status – Food Safety’ and of the Federal Food Safety and Veterinary Office ‘National Surveillance Programme’.
For diseases for which Switzerland does not yet have approval of disease-free status, Switzerland shall present to the Joint Veterinary Committee the information necessary to obtain that status according to the approval criteria set out in Regulation (EU) 2016/429. On the basis of this information, the Joint Veterinary Committee agrees to update the information available on the websites mentioned above.
The Federal Food Safety and Veterinary Office shall immediately notify the Commission of any change in the conditions on which recognition of that status is based for one of the diseases listed in this paragraph. The situation shall be examined within the Joint Veterinary Committee.
Switzerland shall apply the same provisions as those of Article 107 (with the exception of paragraph 6) of Regulation (EU) 2019/6, in conjunction with Article 37(5) thereof on the use of antimicrobial medicinal products in animals intended for production, in accordance with its legislation listed in Section A above.
Switzerland does not authorise either the placing on the market of medicinal products intended for production animals containing one of the antimicrobials or groups of antimicrobials listed in point (2) or (3) of the Annex to Commission Implementing Regulation (EU) 2022/1255 [Commission Implementing Regulation (EU) 2022/1255 of 19 July 2022 designating antimicrobials or groups of antimicrobials reserved for the treatment of certain infections in humans, in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council (OJ L 191, 20.7.2022, p. 58, ELI: http://data.europa.eu/eli/reg_impl/2022/1255/oj).] or the use in production animals of medicinal products for human use containing these antimicrobials or groups of antimicrobials.
Discussions will take place in the Joint Veterinary Committee on amendments to the above-mentioned European Union legislation requiring adaptation of the Swiss provisions.
Therefore, Switzerland shall not be considered as a third country for the purposes of Article 118 of Regulation (EU) 2019/6 until 1 July 2028.
It shall immediately inform the Joint Veterinary Committee of any further changes to its legislation on antimicrobial medicinal products intended for production animals.
This paragraph shall be reviewed by the Joint Veterinary Committee before 1 July 2028.
* Unless indicated otherwise, any reference to an act shall mean that act as amended before 31 December 2025.
European Union | Switzerland
Regulation (EU) 2016/429 of the European Parliament and of the Council of 9 March 2016 on transmissible animal diseases and amending and repealing certain acts in the area of animal health (‘Animal Health Law’) (OJ L 84, 31.3.2016, p. 1) and the delegated and implementing acts based on this Regulation by 31 December 2025;
For provisions on official controls performed by the competent authorities to verify compliance with agri-food chain rules on trade in germinal products between Switzerland and the European Union:
Regulation (EU) 2017/625 of the European Parliament and of the Council of 15 March 2017 on official controls and other official activities performed to ensure the application of food and feed law, rules on animal health and welfare, plant health and plant protection products, amending Regulations (EC) No 999/2001, (EC) No 396/2005, (EC) No 1069/2009, (EC) No 1107/2009, (EU) No 1151/2012, (EU) No 652/2014, (EU) 2016/429 and (EU) 2016/2031 of the European Parliament and of the Council, Council Regulations (EC) No 1/2005 and (EC) No 1099/2009 and Council Directives 98/58/EC, 1999/74/EC, 2007/43/EC, 2008/119/EC and 2008/120/EC, and repealing Regulations (EC) No 854/2004 and (EC) No 882/2004 of the European Parliament and of the Council, Council Directives 89/608/EEC, 89/662/EEC, 90/425/EEC, 91/496/EEC, 96/23/EC, 96/93/EC and 97/78/EC and Council Decision 92/438/EEC (Official Controls Regulation) (Official Controls Regulation) (OJ L 95, 7.4.2017, p. 1);
Commission Implementing Regulation (EU) 2021/403 of 18 March 2021 laying down rules for the application of Regulations (EU) 2016/429 and (EU) 2017/625 of the European Parliament and of the Council as regards model animal health certificates and model animal health/official certificates, for the entry into the Union and movements between Member States of consignments of certain categories of terrestrial animals and germinal products thereof, official certification regarding such certificates and repealing Decision 2010/470/EU (OJ L 113, 31.3.2021, p. 1).
Ordinance of 27 June 1995 on epizootic diseases (OFE; RS 916.401), and in particular Articles 51 to 55a (artificial insemination) and 56 to 58a (transfer of ovum and embryo) thereof;
Ordinance of 18 November 2015 governing trade involving the importation, transit and exportation of animals and animal products with the Member States of the EU, Iceland, Norway and Northern Ireland (OITE-EU; RS 916.443.11);
DFI Ordinance of 18 November 2015 governing trade involving the importation, transit and exportation of animals and animal products with the Member States of the EU, Iceland, Norway and Northern Ireland (OITE-EU-DFI; RS 916,443,111).
Inspections shall be carried out under the responsibility of the Joint Veterinary Committee in accordance in particular with Article 116 of Regulation (EU) 2017/625 and Article 57 of the Law on epizootic diseases.
For the purposes of this Annex, Switzerland is recognised as fulfilling the conditions provided for in Chapter 4 of Part II of Regulation (EU) 2016/429, Commission Delegated Regulation (EU) 2020/689 [Commission Delegated Regulation (EU) 2020/689 of 17 December 2019 supplementing Regulation (EU) 2016/429 of the European Parliament and of the Council as regards rules for surveillance, eradication programmes, and disease-free status for certain listed and emerging diseases (OJ L 174, 3.6.2020, p. 211, ELI: http://data.europa.eu/eli/reg_del/2020/689/oj).] and Commission Implementing Regulation (EU) 2021/620 [Commission Implementing Regulation (EU) 2021/620 of 15 April 2021 laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council as regards the approval of the disease-free and non-vaccination status of certain Member States or zones or compartments thereof as regards certain listed diseases and the approval of eradication programmes for those listed diseases (OJ L 131, 16.4.2021, p. 78, ELI: http://data.europa.eu/eli/reg_impl/2021/620/oj).] as regards the diseases listed in the sites of the Commission ‘Surveillance, eradication programmes and disease-free status – Food Safety’ and of the Federal Food Safety and Veterinary Office ‘National Surveillance Programme’.
For diseases for which Switzerland does not yet have approval of disease-free status, Switzerland shall present to the Joint Veterinary Committee the information necessary to obtain such status according to the approval criteria set out in Regulation (EU) 2016/429. On the basis of this information, the Joint Veterinary Committee agrees to update the information available on the websites mentioned above.
The Federal Food Safety and Veterinary Office shall immediately notify the Commission of any change in the conditions on which recognition of that status is based for one of the diseases listed in this paragraph. The situation shall be examined within the Joint Veterinary Committee.
As regards bovine semen, it is noted that in Switzerland all centres include only animals with a negative serum neutralisation test or ELISA test for infectious bovine rhinotracheitis or infectious pustular vulvo-vaginitis.
For sectors where recognition of equivalence is mutual, germinal products traded between the Member States of the European Union and Switzerland shall move under the same conditions as germinal products traded between the Member States of the European Union. Where necessary, these products shall be accompanied by the health certificates required for trade between the Member States of the European Union and available in the TRACES system.